Clinical Trials Browser

Adenocarcinoma Of Esophagus × tremelimumab × 90 days × Clear all

NCT06824363 2026-01-30

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus